摘要
目的探讨脑钠肽(BNP)在慢性阻塞性肺疾病(COPD)患者中检测的临床意义。方法选择2012年8月至2013年8月收治的COPD患者80例,按病情分为急性加重期为40例,稳定期患者40例。同时选择健康患者40例作为对照组。所有参与研究的对象均空腹抽取2 ml静脉血,检测血浆BNP水平。观察COPD患者与对照组、COPD患者治疗前后BNP水平的差异。结果 COPD患者BNP水平明显高于对照组,而急性加重期患者又明显高于稳定期患者,三组比较差异具有统计学意义(P<0.05)。COPD患者治疗1 d和治疗7 d后,血浆BNP水平较治疗前明显下降,治疗7 d后又比治疗1 d时明显下降,差异均有统计学意义(P<0.05)。急性加重期患者治疗前血浆BNP平均值为176.5±28.7 pg/ml,有18例重度患者转入ICU行机械通气治疗,18例重度患者血浆BNP平均值为351.8±57.3 pg/ml,明显高于急性加重期患者的平均水平,差异具有统计学意义(P<0.05)。结论血浆BNP水平在COPD患者急性加重期、稳定期均有不同程度的升高,其与COPD的严重程度具有密切相关性。
Objective To assess the clinical significance of brain natriuretic peptide（ BNP）in patients with chronic obstructive pulmona-ry disease（ COPD）. Methods Eighty COPD patients treated in our hospital from Aug 2012 to Aug 2013 were divided into 2 groups according to the stage of disease. Forty patients with acute exacerbation of COPD and 40 patients with stable COPD were enrolled in the study. Forty healthy subjects were as control. The serum BNP levels were determined and compared among groups and before and after treatment. Results Serum BNP level in COPD patients was significantly higher than that in control group,and it was higher in acute COPD than that in stable COPD,there was significant difference in BNP level among three groups（ P 〈0. 05）. BNP level was decreased after treatment and it was further decreased after 7days of treatment in comparison with the value of one day treatment（ P 〈0. 05）. The mean BNP in 18 cases of severe COPD who received me-chanical ventilation in ICU（351. 8±57. 3 pg/ml）was significantly higher than that in acute exacerbation COPD patients（ P 〈0. 05）. Conclu-sion Serum BNP levels increase at different degrees in both acute exacerbation and stable COPD,and it closely relates to the severity of COPD.
出处
《临床和实验医学杂志》
2015年第11期893-895,共3页
Journal of Clinical and Experimental Medicine
基金
张家口市科学技术与地震局指令项目子课题(12110043D-3)
关键词
慢性阻塞性肺疾病
急性加重期
稳定期
脑钠肽
Chronic obstructive pulmonary disease
Acute exacerbation of COPD
Stable COPD
Brain natriuretic peptide
